Substance
ID:381104
Names and Identifiers
Synonyms
DFOMN-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid MethanesulfonateBa 33112Deferoxamine B mesylateDeferrioxamine B methanesulfonateN1-(5-aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide MethanesulfonateDFX mesylateDeferoxamine methanesulfonateDesferal mesylateDesferrioxamine B mesylateDesferrioxamine methanesulfonateNSC 644468Deferoxamine Mesylate
IUPAC name
N-(5-aminopentyl)-N-hydroxy-N'-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]carbamoyl}propanamido)pentyl]butanediamide; methanesulfonic acid
IUPAC Traditional name
deferoxamine; methanesulfonic acid
Registration numbers
CAS Number
Properties
Safety Information
MSDS Link
Product Information
Certificate of Analysis
Molecule Details
An iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients
Molecular Spectra
No Data Available
Click here to submit data
References
• Cappellini, M.D. et al.: Hemoblobin, 33, 258 (2010)
• Selim, M.: Translat. Stroke Res., 1, 35 (2010)
• Inati, A. et al.: Am. J. Hematol., 85, 782 (2010)